Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Protein geranylgeranyltransferase type I subunit beta pseudogene 2" (PGGT1BP2) is classified as a pseudogene, meaning it is a DNA sequence closely related to the gene encoding the beta subunit of protein geranylgeranyltransferase type I but presumed non-functional. Pseudogenes are typically not transcribed into proteins and have no known biological or therapeutic function. There is no evidence in the scientific literature or biological databases that this pseudogene encodes a functional protein, plays a biological role, or is a drug target. In summary: This is not a valid or actionable target (enzyme, receptor, transporter, etc.) and is considered a non-functional genomic element. If you require information about the functional geranylgeranyltransferase type I beta subunit (encoded by PGGT1B), or about protein geranylgeranyltransferase in general, please clarify; otherwise, PGGT1BP2 is not a relevant molecule for target-based research or drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein geranylgeranyltransferase type I subunit beta pseudogene 2 (PGGT1BP2).